MET and central nervous system cancer: SGX-523 is a small molecule inhibitor of HGFR/MET tyrosine kinase activity that inhibits tumour cell growth, migration and invasion in a panel of glioma cells in vitro and reduced tumour growth in a murine xenograft model of GBM using the U87MG GBM cell line (Table 2) (93).